期刊文献+

HPLC法测定阿戈美拉汀原料药的有关物质 被引量:3

Determination of Agomelatine related substances by HPLC
下载PDF
导出
摘要 目的:采用HPLC法测定阿戈美拉汀原料药的有关物质。方法:采用Symmtry C18(4.6 mm×250 mm,5μm)色谱柱;流动相A为乙腈:10 mmol磷酸氢二钠(磷酸调节pH至3.5)=30∶70;流动相B为乙腈,梯度洗脱;流速为1.0 mL/min;检测波长为230 nm;柱温为35℃。结果:阿戈美拉汀及其已知杂质(杂质1、杂质2、杂质3和杂质4)的线性范围分别为0.05~1.2μg;平均回收率分别为104.6%、101.3%、104.9%、99.6%;结论:本法简便、准确、适合于阿戈美拉汀原料药有关物质测定。 Objective: To establish an HPLC method to determination related substances of Agomelatine. Methods: The analytical column was Symmtry C18 (4.6 mm× 250 mm, 5 μm) column. The mobile phase A was composed of acetonitrile and 10 mmol/L disodium hydrogen phosphate (with phosphoric acid pH=3.5) (30 : 70), mobile phase B was acetonitrile ,gradient elution; at a flow rate of 1.0 ml/min. The wavelength of UV detector was 230 nm and column temperature was 35 ℃. Results: The linear ranges of Agomelatine and impurities were 0.05-1.2 μg, the average recovery was 104.6 %, 101.3 %, 104.9 %, 99.6 %; Conclusion: This method is convenient and accurate to determine the related substances of Agomelatine.
出处 《广东化工》 CAS 2013年第16期216-216,210,共2页 Guangdong Chemical Industry
关键词 阿戈美拉汀 原料药 HPLC法 梯度洗脱 有关物质 Aliskiren Tablets: API: HPLC method sorhamnetin gradient elution: content determination
  • 相关文献

参考文献4

  • 1Luis S, Belen A. Agomelatine: a novel mechanism of antidepres- sant action involving the melatonergic and serotonergic system.
  • 2何学军,任真,王娟,刘晶,杜宇,乔红群.RP-HPLC测定阿戈美拉汀原料药的含量[J].华西药学杂志,2010,25(2):204-205. 被引量:9
  • 3Loo H, Hate A. Determination of the dose of agomelatine a melatoninergic agonist and selective 5-HT2C antagonist, in the treatment of major depressive disorder : a placebo-controlled dose range study[J]. Inter Clini Psychopharm, 2002, 17: 239-247.
  • 4中国药典2010附录XIXA药品质量标准分析方法验证指导原则.

二级参考文献3

  • 1Luis S,,Belen A.Agomelatine:a novel mechanism of antidepres-sant action involving the melatonergic and serotonergic system[].Europ Psychinary.2008
  • 2Loo H,Hale A.Determination of the dose of agomelatine,a me-latoninergic agonist and selective5-HT2C antagonist,in the treatment of major depressive disorder:a placebo-controlled dose range study[].Inter Clini Psychopharm.2002
  • 3Simonin G,Bru L,Lelievere R,et al.Determination of melatonin in biological fluids in the presence of the melatonin agonist S20098: comparison of immunological techniques and GC-MS methods[].Journal of Pharmaceutical and Biomedical Analysis.1999

共引文献12

同被引文献34

  • 1何学军,任真,王娟,刘晶,杜宇,乔红群.RP-HPLC测定阿戈美拉汀原料药的含量[J].华西药学杂志,2010,25(2):204-205. 被引量:9
  • 2国家食品药品监督管理局药品审评中心.口腔崩解片的剂型特点和质量控制会议纪要[C/OL].[2003-09-25] http://www.cde.org.cn/dzkw.do?method=largePage&id=1383.
  • 3张慧,任麒,沈慧凤.微粒型口腔崩解片的研究概况[J].中国医药工业杂志,2007,38(12):880-884. 被引量:1
  • 4梅兴国,刘洪玉.阿戈美拉汀包衣微丸以及可在口中分散的药物组合物:中国,201110440302.7[P]. 2011 -12 -26.
  • 5ALHUSBAN F,PERRIE Y, MOHAMMED AR. Formulation ofmultiparticulate systems as lyophilised orally disintegrating tablets[J] . Eur J Pharm Biopharm, 2011,79 ( 3 ) :627 - 634.
  • 6YOSHINORI N’ARISA M, SHINY A U,et al. Preparation and e-valuation of unpleasant taste-masked pioglitazone orally disinte-grating tablets [ J ]. Int J Pharm ,2013 ,446 (1 -2) : 160 - 165.
  • 7SYUSUKE S, YASUNORI I’SUSUMU K,et al. Preparation andevaluation of swelling induced-orally disintegrating tablets by mi-crowave irradiation[ J]. Int J Pharm ,2011,416(1):252 - 259.
  • 8SYUSUKE S,YASUNORI I’SHUJI N,e( al. Design and evalua-tion of microwave-treated orally disintegrating tablets containingpolymeric disintegrant and mannitol[ J ]. Int J Pharm ,2013 ,448(1):132 -141.
  • 9LIU Y, CHEN L, JI Y. Quantification and structural elucidationof potential impurities in agomelatine active pharmaceutical ingre-dient [J]. J Pharm Biomed Anal,2013 ,81 - 82 : 193 - 201.
  • 10唐家邓,岑均达.阿戈美拉汀的合成[J].中国医药工业杂志,2008,39(3):161-162. 被引量:18

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部